Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome
Lanlan Zhou, Yanan Liu, Zhenzhen Wen, Shimei Yang, Mingjie Li, Qiuhua Zhu, Shiqiu Qiu, Yanmin Gao, Hong Wang, Yuemei Yuan, Hanling Zhang, Chaolun Chen, Wenbin Zeng, Zebing Guan, Xueyi Pan
Topics & Concepts
MedicineInternal medicineRuxolitinibEtoposideHazard ratioDexamethasoneHemophagocytic lymphohistiocytosisGastroenterologyRegimenLymphomaHematologyConfidence intervalChemotherapySurgeryMyelofibrosisBone marrowDiseaseAutoimmune and Inflammatory Disorders ResearchLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research